LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

Search

STERIS PLC

Suletud

SektorTervishoid

212.09 0.89

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

210.12

Max

216.56

Põhinäitajad

By Trading Economics

Sissetulek

26M

220M

Müük

92M

1.6B

P/E

Sektori keskmine

26.583

49.888

Aktsiakasum

2.83

Dividenditootlus

1.16

Kasumimarginaal

13.869

Töötajad

17,937

EBITDA

48M

317M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+35.35% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

1.16%

2.38%

Järgmine tulemuste avaldamine

5. aug 2026

Järgmine dividendimakse kuupäev

26. juuni 2026

Järgmine aktsia dividendi kuupäev (ex-date)

8. juuni 2026

Turustatistika

By TradingEconomics

Turukapital

-231M

21B

Eelmine avamishind

211.2

Eelmine sulgemishind

212.09

Uudiste sentiment

By Acuity

23%

77%

48 / 344 Pingereas Healthcare

STERIS PLC Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

11. mai 2026, 20:44 UTC

Tulu

Steris: Board Approves New $1B Shr Repurchase Program >STE

11. mai 2026, 20:30 UTC

Tulu

Steris 4Q Cont Ops EPS $2.24 >STE

11. mai 2026, 20:30 UTC

Tulu

Steris 4Q Rev $1.6B >STE

11. mai 2026, 20:30 UTC

Tulu

Steris Sees FY Adj EPS $11.10-Adj EPS $11.30 >STE

11. mai 2026, 20:30 UTC

Tulu

Steris 4Q Adj EPS $2.83 >STE

4. veebr 2026, 21:30 UTC

Tulu

Steris Sees FY Adj EPS $10.15-Adj EPS $10.30 >STE

4. veebr 2026, 21:30 UTC

Tulu

Steris 3Q Rev $1.5B >STE

4. veebr 2026, 21:30 UTC

Tulu

Steris 3Q Adj EPS $2.53 >STE

4. veebr 2026, 21:30 UTC

Tulu

Steris 3Q Cont Ops EPS $1.96 >STE

5. nov 2025, 21:30 UTC

Tulu

Steris 2Q Cont Ops EPS $1.94 >STE

5. nov 2025, 21:30 UTC

Tulu

Steris 2Q Rev $1.5B >STE

5. nov 2025, 21:30 UTC

Tulu

Steris 2Q Adj EPS $2.47 >STE

6. aug 2025, 20:30 UTC

Tulu

Steris 1Q Adj EPS $2.34 >STE

6. aug 2025, 20:30 UTC

Tulu

Steris 1Q Rev $1.4B >STE

Võrdlus sarnastega

Hinnamuutus

STERIS PLC Prognoos

Hinnasiht

By TipRanks

35.35% tõus

12 kuu keskmine prognoos

Keskmine 284.5 USD  35.35%

Kõrge 300 USD

Madal 269 USD

Põhineb 3 Wall Streeti analüütiku instrumendi STERIS PLC 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

3 ratings

2

Osta

1

Hoia

0

Müü

Sentiment

By Acuity

48 / 344 Pingereas Tervishoid

Uudiste sentiment

Väga tugevad tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest STERIS PLC

STERIS plc provides infection prevention products and services worldwide. It operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.
help-icon Live chat